Our blogs explain health conditions and clinical research in a way that is easy to follow, so readers can feel more informed
BMS, Janssen Collab to Advance Next-generation Therapy for Cardiovascular Diseases
Source: https://abm-website-assets.s3.amazonaws.com/dddmag.com/s3fs-public/styles/content_body_image/public/embedded_image/2018/04/shutterstock_619251317.jpg?itok=KTVbwSTk The Janssen Pharmaceutical Companies of Johnson & Johnson announced it has entered a new worldwide collaboration with Bristol-Myers Squibb Company on a program to develop and commercialize Factor XIa (FXIa) inhibitors, including BMS-986177, for the prevention and treatment of...
Lupus Treatment Generates Positive Results in Phase III Clinical Trial
New research indicates that belimumab, a monoclonal antibody therapy that targets a component of the immune system, provides considerable benefits to patients with systemic lupus erythematosus (SLE), a predominately female, chronic inflammatory disease that can affect virtually any organ. The Arthritis &...
Artificial Pancreas is a Safe and Effective Treatment for Type 1 Diabetes
Use of an artificial pancreas is associated with better control of blood sugar levels for people with type 1 diabetes compared with standard treatment, finds a review of the available evidence published by The BMJ today. The findings show that artificial pancreas...
Merck’s Ebola shot delivers antibodies that could last 2 years or more, study finds
Previous studies have shown that Merck & Co.’s Ebola vaccine can act fast and can maintain an antibody response for at least one year. Now, a new study has doubled that estimate. The new study, published in Lancet Infectious Diseases, shows antibodies persist for two years after...
FDA Permits Marketing of Artificial Intelligence-Based Device to Detect Certain Diabetes-Related Eye Problems
On April 11, 2018, the U.S. Food and Drug Administration permitted marketing of the first medical device for diabetic retinopathy detection, employing artificial intelligence. Diabetic retinopathy occurs when high levels of blood sugar lead to damage in the blood vessels of...
Personalized Tumor Vaccine Shows Promise in Pilot Trial
A new type of cancer vaccine harnesses tumor immunity has yielded promising results in an initial clinical trial conducted at the Perelman School of Medicine at the University of Pennsylvania and the Abramson Cancer Center of the University of Pennsylvania. The...
Merck’s Keytruda upends lung cancer market with latest survival win
Merck’s Keytruda already has the immuno-oncology lead in non-small cell lung cancer, and it’s making sure it stays that way. On Monday, it rolled out new monotherapy data that could significantly expand its patient pool. In a closely watched trial, the...
Molecular Scissors” May Cut Off Diseases Like HIV
One way to fight diseases including HIV infection and autoimmune disorders could involve changing how a naturally occurring enzyme called SAMHD1, an immune response regulator, works to influence the immune system, new research suggests. The study, led by researchers from The...
The top 15 drug patent expirations of 2018
Each year, dozens of branded pharmaceutical products lose their patent protection in a process that routinely paves the way for cheap generics. This year is no different, and the drugs opening up to copycat competitors represent some serious sales heft. And...
Gene That Causes Neurodevelopmental Disorders, Including Autism, IDed
A study led by researchers at McMaster University has pinpointed a gene that is responsible for neurodevelopmental disorders, including autism. Researchers found alterations of the gene thousand and one amino-acid kinases 2, known as TAOK2, plays a direct role in these...
Merck’s Keytruda shows up its rivals with NICE backing in bladder cancer
Merck just accomplished a feat its rivals haven’t so far. Friday, England’s National Institute for Health and Care Excellence, the company’s Keytruda to treat certain bladder cancer patients, making it the first immuno-oncology med to win the cost watchdog’s favor for that use....
Researchers Adapt HIV Test in Developing Rapid Diagnostic Test for Zika Virus
Researchers at New York University College of Dentistry (NYU Dentistry), in collaboration with Rheonix, Inc. (Ithaca, NY), are developing a novel test for the Zika virus that uses saliva to identify diagnostic markers of the virus in a fraction of the...